# Letter to the Editor: “TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas”

**Authors:** Lisa Feinstein

PMC · DOI: 10.3389/fonc.2025.1686095 · Frontiers in Oncology · 2025-10-07

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}
- **Diseases:** mucinous ovarian carcinomas (MESH:D010051)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12537352/full.md

---
Source: https://tomesphere.com/paper/PMC12537352